Journal of Genetic Engineering and Biotechnology, published by Elsevier Science Inc, is a prestigious open-access journal that stands at the forefront of research in the fields of biotechnology and genetics. Since its inception in 2011, the journal has provided a platform for cutting-edge studies that explore the complexities and innovations within genetic engineering and its applications in biotechnology. With a commendable Impact Factor and recognized as a Q2 journal in both biotechnology and genetics as per 2023 categorization, it ranks well within Scopus, evidencing its influence in the scientific community. Researchers and professionals accessing articles published in this journal benefit from timely contributions that bridge theoretical and practical aspects of genetic technologies. By fostering a collaborative environment, the Journal of Genetic Engineering and Biotechnology aims to promote advancements that drive science forward, making it an essential resource for students, academics, and industry practitioners alike. For those interested in making their mark in these rapidly evolving fields, this journal offers unparalleled access to high-quality, peer-reviewed research.

Genes is a leading open-access journal published by MDPI that focuses on advancing the field of genetics and genomics. Established in 2010 and based in Basel, Switzerland, this journal has made significant strides in promoting innovative research in both clinical genetics and molecular biology. With an impact factor reflecting its relevance and quality, Genes has been classified in the Q2 quartile for Genetics and the Q3 quartile for clinical Genetics as of 2023. The journal provides an accessible platform for researchers, professionals, and students to disseminate their findings and explore emerging trends across the genetics landscape. Accessible online since its inception, Genes allows for continuous engagement and collaboration within the scientific community, fostering a deeper understanding of genetic mechanisms and their implications in health and disease.

NAR Cancer, published by Oxford University Press, is a pioneering open access journal established to advance the rapidly evolving field of cancer research. Since its inception in 2019, this journal has gained substantial recognition, achieving a prestigious Q1 ranking in both Cancer Research and Oncology categories as of 2023. With a focused objective to disseminate high-quality research, reviews, and insights into innovative cancer treatments and diagnostics, NAR Cancer serves as an essential platform for researchers, healthcare professionals, and students alike. The journal is accessible for all since it became open access in 2020, ensuring a global reach and impact. Positioned in the competitive landscape of oncology, with impressive Scopus rankings, it offers a unique opportunity for contributors to share their work with an engaged and interdisciplinary audience. With a commitment to excellence, NAR Cancer is dedicated to driving forward the understanding and management of cancer worldwide.

MOLECULAR GENETICS AND GENOMICS is a distinguished journal published by SPRINGER HEIDELBERG that serves as a pivotal platform for the communication of cutting-edge research and developments in the fields of genetics, molecular biology, and medicine. With an ISSN of 1617-4615 and an E-ISSN of 1617-4623, this journal has established itself since its inception in 1994 as a significant resource for researchers aiming to explore the complexities of genetic interactions and their implications in various biological systems. The journal is indexed in Scopus, with respectable rankings in the Genetics, Molecular Biology, and Biochemistry categories, showcasing its position within the academic community. It is categorized in the 2023 rankings as Q3 in Genetics, Q2 in Medicine (miscellaneous), and Q3 in Molecular Biology, indicating its relevance and quality in the scientific discourse. The journal also promotes open access, ensuring that researchers and professionals can easily share and advance knowledge in the rapidly evolving disciplines of molecular genetics and genomics. As the journal continues to bridge the gap between experimental and theoretical research, it presents a vital space for innovation, fostering collaborations and scholarly exchange among its readership.

GENOMICS is a prestigious journal published by Academic Press Inc Elsevier Science, dedicated to advancing the field of genetic research and molecular biology. With an impressive impact factor, this journal is recognized for its rigorous peer-review process and high-quality publications that cover a wide range of topics within the genomics discipline. Operating from the United States, GENOMICS has established itself as a vital resource for researchers, professionals, and students alike, standing at Q2 in the Genetics category according to the latest rankings. With a rich history dating back to 1987 and convergence extending to 2024, the journal highlights cutting-edge discoveries and methodologies, ensuring that its readership remains at the forefront of genetic advancements. Although currently not an open-access journal, articles published within its pages are often accessible through various academic platforms, enhancing worldwide reach and dissemination. For those engaged in the fields of biochemistry, genetics, and molecular biology, GENOMICS serves as an indispensable platform for impactful research and collaborative initiatives.

International Journal of Genomics is a pivotal open-access publication under the esteemed HINDAWI LTD, dedicated to advancing the fields of genomics, biochemistry, genetics, and molecular biology. Established in 2013, this journal aims to disseminate innovative research findings and foster scholarly dialogue among researchers, professionals, and students alike. With a robust Impact Factor reflective of its commitment to quality, the journal has achieved a Q3 ranking in Biochemistry, Genetics, and Molecular Biology, as well as notable placements in Pharmaceutical Science, indicating its broad relevance and influence in these interconnected fields. The journal is indexed in esteemed databases, ensuring high visibility and accessibility for published works. As an open-access journal, it prioritizes the sharing of knowledge across borders, facilitating greater collaboration and advancement in genomic research globally. Join the academic community in exploring the vast potential of genomics through the International Journal of Genomics, based in Egypt, and reaching audiences worldwide from its London office.

GENOMICS PROTEOMICS & BIOINFORMATICS, published by Elsevier, stands at the forefront of cutting-edge research in the fields of genomics, proteomics, and bioinformatics. This esteemed journal, with an impact factor reflecting its significant influence, has embraced an Open Access model since its inception in 2003, ensuring that knowledge is freely accessible to a global community of researchers, professionals, and students. Based in China, it has been recognized for its exemplary contributions, achieving Q1 quartile rankings in major categories such as Biochemistry, Computational Mathematics, Genetics, and Molecular Biology as of 2023. Moreover, its commendable Scopus rankings position it among the top journals in its fields, with outstanding percentile performances that highlight its scholarly impact. As it continues to converge from 2003 to 2024, the journal aims to foster innovation and collaboration, making it an essential platform for disseminating vital insights and advancements in molecular life sciences.

aBIOTECH, published by SPRINGERNATURE, is a premier academic journal dedicated to advancing the fields of biotechnology, agronomy, and molecular biology. With an impressive ISSN of 2096-6326 and E-ISSN 2662-1738, this journal has established itself as a vital resource for researchers and professionals aiming to publish high-quality, impactful studies. Based in Singapore, aBIOTECH has achieved remarkable recognition, boasting a Q1 ranking in multiple categories including Agronomy and Crop Science, Biochemistry, and Genetics in the 2023 Scopus rankings. Its solid position in the 90th percentile for Biochemistry and Genetics reinforces its significance within the global scientific community. The journal covers a broad spectrum of topics relevant to both basic and applied research, facilitating a shared dialogue amongst scientists and encouraging collaborative progress in innovative biotechnological applications. The open-access nature of the journal ensures that cutting-edge research is freely available, fostering a global exchange of ideas that is critical to the advancement of science today.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.